EnteraSense secures $4M in funding for bleed-detecting GI tract capsule — 4 insights

EnteraSense secured $4 million (€3.5 million) in funding for its gastrointestinal tract bleed-detecting capsule, Med-Tech Innovation News reports.

Here's what you should know:

1. The capsule monitors unexpected bleeding in postsurgical patients.

2. If a physician suspects GI bleeding, the capsule detects it quickly.

3. EnteraSense won a European Union Horizon 2020 grant and secured private investor funding.

4. EnteraSense will conduct in-human studies in 2019, with the goal of earning regulatory approval in 2020.

More articles on gastroenterology:
The PE arms race — From the deal heard round the world to what's next in GI
The strategy behind Pardee UNC's $16M ASC
ASC supply chain tip of the day: Find an accountability structure

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months